nicotine has been researched along with Akinetic-Rigid Variant of Huntington Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al Deeb, S; Al Moutaery, K; Elfaki, I; Khan, HA; Tariq, M | 1 |
| Blessed, G; Candy, JM; Dick, DJ; Edwardson, JA; Fairbairn, A; Perry, EK; Perry, RH; Smith, CJ | 1 |
2 other study(ies) available for nicotine and Akinetic-Rigid Variant of Huntington Disease
| Article | Year |
|---|---|
Neuroprotective effect of nicotine against 3-nitropropionic acid (3-NP)-induced experimental Huntington's disease in rats.
Topics: Animals; Corpus Striatum; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Down-Regulation; Drug Interactions; Female; Glutathione; Huntington Disease; Injections, Subcutaneous; Motor Activity; Nerve Degeneration; Neuroprotective Agents; Nicotine; Nicotinic Agonists; Nitro Compounds; Oxidative Stress; Propionates; Rats; Rats, Wistar; Receptors, Nicotinic; Tyrosine 3-Monooxygenase | 2005 |
Nicotinic receptor abnormalities in Alzheimer's and Parkinson's diseases.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Alzheimer Disease; Dementia; Hippocampus; Humans; Huntington Disease; Middle Aged; Nicotine; Parkinson Disease; Receptors, Nicotinic; Thalamus | 1987 |